Manulife (Manufacturers Life Insurance)
NAMS icon

Manulife (Manufacturers Life Insurance)’s NewAmsterdam Pharma NAMS Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.26M Buy
96,232
+84,930
+751% +$2.8M ﹤0.01% 1373
2026
Q1 		$362K Sell
11,302
-11,396
-50% -$371K ﹤0.01% 2279
2025
Q4 		$792K Buy
22,698
+193
+0.9% +$7.02K ﹤0.01% 1972
2025
Q3 		$640K Buy
22,505
+11,637
+107% +$279K ﹤0.01% 2087
2025
Q2 		$197K Buy
10,868
+544
+5% +$9.92K ﹤0.01% 2569
2025
Q1 		$211K Buy
10,324
+1,708
+20% +$38K ﹤0.01% 2474
2024
Q4 		$221K Buy
+8,616
New +$183K ﹤0.01% 2580

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s NAMS Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) increased its NewAmsterdam Pharma (NAMS) stake by 751% in Q2 2026, buying an estimated $2.8M and bringing the position to 96,232 shares worth $3.26M. The position accounts for ﹤0.01% of the portfolio, ranked #1373.

Manulife (Manufacturers Life Insurance) first reported a position in NAMS in Q4 2024 and has held it in 7 quarters since. 194 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 96,232 shares of NewAmsterdam Pharma worth $3.26M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) bought 84,930 NewAmsterdam Pharma shares in Q2 2026, an estimated $2.8M.
  • NewAmsterdam Pharma made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #1373 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in NewAmsterdam Pharma in Q4 2024 and has held it in 7 quarters since.
  • 194 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.